Target intelligence / Profile preview

Monocyte cytokine secretion

Molecular classification
Biological process
01

Overview

Monocyte cytokine secretion is a fundamental physiological process by which monocytes synthesize and release a variety of signaling proteins, such as TNF-alpha, IL-1, and IL-6, to coordinate the innate immune response and inflammation. This process is typically initiated when pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), detect pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (PubMed: 25482231). Once activated, intracellular signaling cascades involving kinases like JAK, MAPK, and the transcription factor NF-kappaB regulate the expression and secretion of these potent inflammatory mediators (PubMed: 12692225). While critical for host defense, the dysregulated or excessive secretion of cytokines by monocytes is a primary driver of pathology in autoimmune diseases, sepsis, and cytokine storm syndromes (NIH: National Institute of Allergy and Infectious Diseases). Drugs like corticosteroids and various kinase inhibitors modulate this process by interfering with the signaling pathways that lead to cytokine gene transcription (PubMed: 11163400). However, because 'Monocyte cytokine secretion' describes a multi-step biological phenotype rather than a specific molecular entity like a receptor or enzyme, it is classified as a functional endpoint in pharmacology rather than a discrete therapeutic target.

Other names
Monokine productionMonocyte-derived cytokine releaseMonocyte inflammatory responseMonocyte secretome
02

Mechanism of action

Inhibition of intracellular signaling pathways such as NF-kappaB, MAPK, or JAK/STAT, and the suppression of transcriptional regulation or processing of cytokine precursors.

03

Biological functions

Immune responseInflammationCell signalingInnate immunityChemotaxis
04

Disease associations

InflammationAutoimmune diseaseSepsisCytokine release syndromeRheumatoid arthritisCancer
05

Safety considerations

Increased susceptibility to opportunistic infectionsDelayed wound healingSystemic immunosuppressionPotential for reactivation of latent infections (e.g., Tuberculosis)
06

Interacting drugs

Dexamethasone

5 more in the full profile.

07

Biomarkers

Tumor Necrosis Factor-alpha (TNF-alpha)Interleukin-1 beta (IL-1b)Interleukin-6 (IL-6)Monocyte Chemoattractant Protein-1 (MCP-1)Interleukin-10 (IL-10)

Beyond the preview

Go deeper on Monocyte cytokine secretion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monocyte cytokine secretion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call